Otsuka Pharmaceutical Co., Lt v. Thomas Price
Court of Appeals for the D.C. Circuit
1Opinion of the Court
SRINIVASAN, Circuit Judge:
The Food, Drug, and Cosmetic Act affords periods of “marketing exclusivity” to pioneering drug products. When a drug earns a period of exclusivity, the Food and Drug Administration must withhold approval of certain competing drugs if various conditions are satisfied. But how does the FDA determine if a new drug bears a sufficiently close relationship to a pioneering drug to fall within the latter’s zone of exclusivity? This case concerns the FDA’s test for making that determination.
The two drugs at issue in this case are antipsychotics primarily used to treat…
2Cases cited7 opinions
- Chevron U. S. A. Inc. v. Natural Resources Defense Council, Inc.Supreme Court of the United States · 1984
- Federal Communications Commission v. Fox Television Stations, Inc.Supreme Court of the United States · 2009
- Sullivan v. StroopSupreme Court of the United States · 1990
- Commissioner v. LundySupreme Court of the United States · 1996
- Cablevision Systems Corp. v. Federal Communications CommissionCourt of Appeals for the D.C. Circuit · 2011
2 more not listed; retrieve them via the Exa API.
3Cited by16 opinions
- Eagle Pharmaceuticals, Inc. v. Alex Azar, IICourt of Appeals for the D.C. Circuit · 2020
- Michael Lissack v. Cmsnr. IRSCourt of Appeals for the D.C. Circuit · 2023
- Braeburn Inc. v. U.S. Food & Drug Admin.Court of Appeals for the D.C. Circuit · 2019
- Amgen Inc. v. HarganCourt of Appeals for the D.C. Circuit · 2018
- Otay Mesa Prop., L.P. v. U.S. Dep't of the InteriorCourt of Appeals for the D.C. Circuit · 2018
11 more not listed; retrieve them via the Exa API.